ArticleCureus2026
Embracing Large Language Models for Medical Applications, Part II: Building a Framework for Clinical Stewardship.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large language models (LLMs) have moved rapidly from experimental demonstrations to early clinical, educational, and administrative use. The first phase of medical LLM discourse emphasized opportunities in transfer learning, domain adaptation, clinical decision support, education, privacy, fairness, and regulation. The next phase requires a more specific framework for clinical stewardship. Since 2023, medical LLMs have demonstrated substantial progress in medical question answering, diagnostic reasoning in interactive clinical dialogue, patient communication, documentation support, and retrieval-augmented knowledge synthesis. At the same time, prospective and randomized evaluations show that model performance alone does not guarantee improved physician reasoning, safer decisions, or better patient outcomes. The central challenge is therefore implementation: defining appropriate use cases, validating models in context, training clinicians, protecting patients, and monitoring deployed systems across their lifecycle. This Viewpoint proposes a practical roadmap for medical LLM adoption. We distinguish lower-risk administrative and communication tasks from higher-risk diagnostic, triage, and treatment tasks. We argue for tiered evidence standards, transparent reporting, local validation, human oversight, equity auditing, patient-centered consent, and continuous post-deployment surveillance. The regulatory environment has also matured, with risk-based frameworks and lifecycle-oriented oversight increasingly shaping how these systems are evaluated and maintained. LLMs should be treated as workflow-embedded sociotechnical systems, whose performance depends on the interaction among models, clinicians, patients, interfaces, local data, and governance. Responsible adoption will require collaboration among clinicians, clinical informaticians, health systems, patients, regulators, ethicists, and developers. Realizing the promise of medical LLMs depends on a shift from fascination with fluent outputs toward disciplined stewardship of clinical performance, accountability, equity, and trust.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.